Marksans Pharma | Subscribe to view

Is the company worth investing in (now)?: Subscribe to view

338.60

18.80 | 5.88%

Price

Healthcare - Pharma Research & Development

Price Trend

4%
Price 14 Day

Past → Today

3%
Price 30 Day

Past → Today

30%
Price 90 Day

Past → Today

Overview
How is the Stock? Price: Price Looks Overvalued (Considering All Variables The Stock Looks Looks Overvalued) & Fundamentals Only Reasonable
Overall Score (Remark) Subscribe to view
Is It A Fundamentally Strong Company? Fundamentals Only Reasonable
Fundamental Strength Score [out of 5] 3.14
Overview
Subscribe to view more...